Cure Pharmaceuticals makes licensing deal with Vanguard Scientific

You are here: Home > Biotech > Current Article

Cure Pharmaceuticals makes licensing deal with Vanguard Scientific

By Staff Report / Thursday, February 13th, 2020 / Comments Off on Cure Pharmaceuticals makes licensing deal with Vanguard Scientific

Cure Pharmaceuticals announced a licensing deal with Oregon-based Vanguard Scientific for its cannabis extraction technology. Oxnard drug delivery and cannabis research firm Cure develops thin dissolvable strips for oral drug delivery. The agreement allows Vanguard, which provides equipment for botanical extraction, to use its patents on isolating cannabinoids using various solvents like CO2 and developing…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.